EUMEDICA
ActiveSummary
EUMEDICA has been active since 1951 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €26.31M and a net result of €7.17M. Equity is growing by ~9.6% per year across the filed fiscal years. Its solvency ranks better than 47% of 4867 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
78
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability82▲+3
Solvency68▲+1
Growth65▲+1
Track record100
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2M at 30 days acceptable
Liquidity tight (current ratio 1.48 against 1.46 in 2024; short-term debt: 44.3% and cash: 24.2% of total assets), and 57% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
43%
Return on assets
11.7%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-07-2026, 16 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
16 d early
2024
15 d early
2023
23 d late
2022
9 d late
2021
45 d late
2020
30 d late
2019
34 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
€81.21M▲ 2.8%
2024 · €78.99M
2018: €72.80M
2019: €76.16M
2020: €76.53M
2021: €77.86M
2022: €62.71M
2023: €68.69M
2024: €78.99M
2018 → 2025
EBIT margin
12.3%▲ 2.5pp
2024 · 9.8%
2018: 2.4%
2019: 1.6%
2020: 0.3%
2021: 0.8%
2022: 1.7%
2023: 8.6%
2024: 9.8%
2018 → 2025
Net result
€7.17M▲ 23.0%
2024 · €5.83M
2018: €1.35M
2019: €787k
2020: €144k
2021: €567k
2022: €527k
2023: €4.34M
2024: €5.83M
2018 → 2025
Working capital
€12.92M▲ 31.1%
2024 · €9.86M
2018: €2.74M
2019: €3.44M
2020: €3.41M
2021: €1.47M
2022: €1.88M
2023: €4.82M
2024: €9.86M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€77.86M-€62.71M▼ 19.4%€68.69M▲ 9.5%€78.99M▲ 15.0%€81.21M▲ 2.8%
Equity€13.85M-€14.18M▲ 2.4%€17.53M▲ 23.6%€21.97M▲ 25.3%€26.31M▲ 19.8%
Operating result€598k-€1.07M▲ 78.7%€5.89M▲ 451%€7.76M▲ 31.6%€9.99M▲ 28.8%
Net result€567k-€527k▼ 7.1%€4.34M▲ 724%€5.83M▲ 34.2%€7.17M▲ 23.0%
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2025 is 29% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €61.18M
Fixed assets
€21.18M ▲ 1.9%
Current assets
€40.00M ▲ 27.5%
Equity and liabilities €61.18M
Equity
€26.31M ▲ 19.8%
Provisions
€102k ▼ 0.2%
Debt
€34.76M ▲ 15.5%
Debt's share of the balance-sheet total falls from 57.7% to 56.8%. Equity and debt are higher.
Key figures and ratios
EBITDA
€12.18M▲
2024 · €10.13M
Cash flow
€9.36M▲
2024 · €8.21M
Current ratio
1.48▲
2024 · 1.46
Quick ratio
1.46▲
2024 · 1.44
Debt to equity
1.32▼
2024 · 1.37
ROE
27.2%▲
2024 · 26.5%
ROA
11.7%▲
2024 · 11.2%
Interest coverage
102.31▼
2024 · 115.23
Debt ≤ 1 year
€27.08M▲
2024 · €21.51M
Debt > 1 year
€6.94M▼
2024 · €7.86M
Income taxes
€2.56M▲
2024 · €2.07M
Staff costs
€13.23M▲
2024 · €11.81M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 92 lines
Balance sheet
Code20242025
Assets
Total assets20/58€52.16M€61.18M▲
Fixed assets21/28€20.79M€21.18M▲
Tangible fixed assets22/27€20.77M€21.12M▲
Land and buildings22€17.76M€16.15M▼
Plant, machinery and equipment23€1.95M€1.80M▼
Furniture and vehicles24€582k€334k▼
Other tangible fixed assets26€594€338▼
Assets under construction and advance payments27€486k€2.84M▲
Financial fixed assets28€13k€60k▲
Affiliated companies280/1€111€111=
Participating interests280€111€111=
Other financial fixed assets284/8€13k€60k▲
Shares284€37€37=
Amounts receivable and cash guarantees285/8€13k€60k▲
Current assets29/58€31.38M€40.00M▲
Stocks and contracts in progress3€365k€385k▲
Stocks30/36€365k€385k▲
Raw materials and consumables30/31€211k€130k▼
Goods purchased for resale34€154k€255k▲
Amounts receivable within one year40/41€22.26M€24.16M▲
Trade receivables40€21.31M€21.47M▲
Other amounts receivable41€950k€2.70M▲
Cash at bank and in hand54/58€7.96M€14.82M▲
Deferred charges and accrued income490/1€787k€628k▼
Equity and liabilities
Total equity and liabilities10/49€52.16M€61.18M▲
Equity10/15€21.97M€26.31M▲
Contributions10/11€735k€735k=
Capital10€735k€735k=
Issued capital100€735k€735k=
Reserves13€2.39M€3.39M▲
Non-distributable reserves130/1€73k€73k=
Legal reserve130€73k€73k=
Tax-exempt reserves132€1.17M€2.00M▲
Distributable reserves133€1.15M€1.32M▲
Profit (loss) carried forward14€17.81M€20.78M▲
Investment grants15€1.03M€1.41M▲
Provisions and deferred taxes16€102k€102k▼
Provisions for liabilities and charges160/5€95k€95k=
Other liabilities and charges164/5€95k€95k=
Deferred taxes168€7k€7k▼
Amounts payable17/49€30.09M€34.76M▲
Amounts payable after more than one year17€7.86M€6.94M▼
Financial debts170/4€7.86M€6.94M▼
Credit institutions173€7.86M€6.94M▼
Amounts payable within one year42/48€21.51M€27.08M▲
Current portion of amounts payable after more than one year42€920k€1.58M▲
Trade debts44€16.20M€18.36M▲
Suppliers440/4€16.20M€18.36M▲
Taxes, remuneration and social security45€2.96M€3.70M▲
Taxes450/3€1.02M€1.67M▲
Remuneration and social security454/9€1.94M€2.04M▲
Other amounts payable47/48€1.44M€3.44M▲
Accrued charges and deferred income492/3€718k€750k▲
Income statement
Code20242025
Operating income70/76A€82.20M€86.21M▲
Turnover70€78.99M€81.21M▲
Other operating income74€3.16M€4.99M▲
Non-recurring operating income76A€52k€14k▼
Operating charges60/66A€74.45M€76.22M▲
Goods for resale, raw materials and consumables60€48.29M€47.40M▼
Purchases600/8€48.18M€47.42M▼
Change in stocks: decrease (increase)609€114k€-20k▼
Services and other goods61€11.95M€13.26M▲
Remuneration, social security and pensions62€11.81M€13.23M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2.38M€2.19M▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€-187k€-9k▲
Other operating charges640/8€151k€154k▲
Non-recurring operating charges66A€52k€4k▼
Operating profit (loss)9901€7.76M€9.99M▲
Financial income75/76B€506k€487k▼
Recurring financial income75€506k€487k▼
Income from current assets751€30k€145k▲
Other financial income752/9€475k€341k▼
Financial charges65/66B€365k€742k▲
Recurring financial charges65€365k€742k▲
Debt charges650€88k€119k▲
Other financial charges652/9€277k€623k▲
Profit (loss) for the period before taxes9903€7.90M€9.73M▲
Transfer from deferred taxes780€4k€228▼
Income taxes67/77€2.07M€2.56M▲
Taxes670/3€2.07M€2.56M▲
Tax adjustments and reversals of tax provisions77€284€155▼
Profit (loss) for the period9904€5.83M€7.17M▲
Transfer from tax-exempt reserves789€4k€168k▲
Transfer to tax-exempt reserves689€1,000k€1,000k=
Profit (loss) for the period to be appropriated9905€4.83M€6.34M▲
Appropriation of the result
Profit (loss) to be appropriated9906€19.01M€24.15M▲
Profit (loss) brought forward from the previous period14P€14.18M€17.81M▲
Transfer to equity691/2-€168k
To other reserves6921-€168k
Profit to be distributed694/7€1.20M€3.20M▲
Return on contributions (dividend)694€1.20M€3.20M▲
Social balance
Average headcount (FTE)9087145.1155.6▲
The notes to these accounts (78 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
15-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
31-12
Financial
Highest result since 2018net €7.17M ▲23%
Operating result €9.99M, net result €7.17M, both a record.
31-12
Financial
Equity above €25MEq €26.31M ▲19.8%
8 profitable years in a row build equity to €26.31M.
16-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
23-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 23 days late
2023
09-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 9 days late
2022
14-09
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 45 days late
2021
30-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 30 days late
2020
31-12
Financial
Weakest financial yearnet €144k ▼81.7%
Net result drops to €144k, the lowest in the series; recovery starts the following year.
03-09
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 34 days late
2019
08-08
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 8 days late
2018
14-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 14 days late
2017
03-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 3 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
22 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Manage · 2 establishment units since 2001
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Chemin de la Nauwelette 17170 ManageGround area
3.5 ha
Building footprint
3,808 m²
2 parcels, Wallonia. Linked by address, not a title deed.
2 establishment units
EUMEDICA SA
since 20012.017.791.228
Eumedica Scailmont
since 20212.327.690.093
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52043E0115/00G000 | Wallonia | 3.4 ha | 1 · 3,808 m² | - |
| 52043F0400/00F002indicative | Wallonia | 1,113 m² | - | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
1 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteManage2.017.791.228
Legal Entity Identifier
967600HGAF35MCYT5061
Similar companies · same sector, comparable size
SONOVA BELGIUM
BE 0458.388.445
Dilbeek · Eq €26.95M
DEPHARM
BE 0445.912.760
Wavre · Eq €25.30M
SMITH & NEPHEW
BE 0474.619.911
Zaventem · Eq €27.71M
H & H PHARMACEUTICALS
BE 0759.775.660
Nivelles · Eq €27.77M
Viatris GX
BE 0885.805.780
Hoeilaart · Eq €27.94M
Of 1,898 companies in sector 46460 we hold annual accounts for 1,116. 292 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded01-01-1951
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
Sources
Crossroads Bank for EnterprisesNational Bank · 49 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.